| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |